| INTRODUC TI ON
Periodontal disease is a chronic infectious inflammation, which influences periodontal tissue and gradually destroys alveolar bone.
The periodontal tissue, which surrounds and supports the teeth, is composed of different types of tissues such as gingivae, cementum, periodontal ligament, and alveolar bone.
1 Bacterial plaque induces host inflammation, and continuous inflammatory reaction induces destruction of periodontal tissue. Periodontal disease is characterized by apical migration of the epithelium with periodontal pocket formation, alveolar bone resorption, and destruction of periodontal tissue. 2 It is also well known that multiple risk factors accelerate periodontitis.
Recently, many papers reported that nuclear factor kappa-B
(NF kappa-B) is involved with the pathogenesis of cardiovascular disease, especially in the inflammatory pathway. 3, 4 Its activation requires phosphorylation of I kappa-B by the I kappa-B kinase (IKK)
complex. In recent years, IKK inhibitors, which are novel synthesized chemical compounds, have been developed. It is the phosphorylation inhibitors of I kappa-B, which acts through the inhibition of IKK-alpha and/or IKK-beta and regulates the inflammation. 5 In the present study, we used IMD-0354, a novel IKK inhibitor, and a ligature-induced periodontitis model in mice. Many reports indicate the significant effect of IMD-0354 on the treatment of myocardial ischemia, atopic dermatitis, bronchial asthma, pulmonary fibrosis, and breast cancer. 3, [5] [6] [7] Moreover, in a phase I clinical study, it was
shown that transcutaneous administration of IMD-0354 and IMD-1041, which is a prodrug of IMD-0354 that can be administrated orally, was applied safely in patients with type 2 diabetes, hay fever, and atopic dermatitis. 8 The effect of the reagent on periodontitis, however, has not been studied yet. Thus, the aim of this study was to examine the effect of the reagent on bone loss caused by ligatureinduced periodontitis.
| MATERIAL AND ME THODS

| Animals
C57BL/6J mice (n = 45, the average weight: 22.8 ± 0.17 g), which
were specific-pathogen-free and wild-type, were purchased from Nihon Crea (Tokyo, Japan). The mice were kept in individually ventilated cages and provided sterile food and water under specificpathogen-free conditions. In this study, we used 8-week-old mice.
Maxillary right second molars (M2s) were ligated and used as the test side. Finally, they all were sacrificed 8 days after ligation by an overdose of chloral hydrate. All protocols for animal use were reviewed and approved (A2017-035C) by the Animal Care Committee of the Experimental Animal Center at Tokyo Medical and Dental University.
| Placement of ligatures
To initiate periodontitis artificially, the maxillary right M2s of the mice were ligated with 6-0 silk ligatures. After the administration of three types of mixed anesthetic agents (hydrochloric acid medetomidine, midazolam, and butorphanol tartrate) into the animals, the ligatures were tied gently to care for the periodontal tissue and held around each tooth of all mice during the experimental period. The ligature was put through the interdental space between the second molar (M2) and the third molar (M3) using Dumont forceps (Fine Science Tools, North Vancouver, BC, Canada). The suture was put through the space between the first molar (M1) and second molar (M2). To prevent slack, it was looped around the M2 by suture-tying forceps and was tied firmly by a triple knot. For the split-mouth model, the maxillary M2 at the contralateral side of each mouse was left intact as the control side throughout the same period. 
| Reagents
IMD-0354 (N-(3,5-bis-trifluoromethyl-phenyl)-5-chloro-2-hydroxybenzamide), which was provided by the Institute of Medical Molecular Design (Tokyo, Japan), was applied for the mice in the test group. Before use, it was immediately diluted with 0.5% carboxymethylcellulose (CMC) vehicle (Sigma, Tokyo, Japan). Only 0.5% CMC solution was applied for the mice in the control group as drug-free vehicle. 3 The efficacy, general or cellular toxicity, and pharmacological mechanism by IMD-0354 have been studied in previous reports. 3, 10, 11 The drug safety of the reagent has been also reported in a previous study. 
| Treatment protocols and determination of the IMD-0354 concentration
The animals were randomly divided into two groups. The test mice were injected intraperitoneally with IMD-0354 in a single bolus 5 minutes before the placement of the ligature according to the previous report. 3 The control mice were injected with CMC by following the same treatment protocol as the IMD group mice stated above.
The mice in both groups were treated with each reagent daily and sacrificed on day 8 after the ligation.
To determine the optimum concentration of the IMD-0354 on ligature-induced periodontitis, we performed the ligature experiment stated above for 8 days. IMD-0354 (1, 5, and 10 mg/kg; n = 8, 7, and 9, respectively) or CMC (n = 9) was injected intraperitoneally according to the previous report. 
| Micro-CT analysis of bone resorption
Skulls were harvested from the animals immediately after sacrifice. The composition of all the animals for this analysis was n = 8
(1 mg/kg of IMD-0354), n = 7 (5 mg/kg of IMD-0354), n = 9 (10 mg/ kg of IMD-0354), and n = 9 (CMC group), respectively. All of the hemi-maxilla samples were fixed with 4% paraformaldehyde, and the samples were scanned in all three spatial planes at a resolution of 1024 × 1024 × 1024 voxels by CT scanning of SMX-100CT
(Shimadzu, Kyoto, Japan). After that, we used a desktop micro-CT system (3DBON, Ratoc Corporation, Tokyo, Japan) for the analysis of the data. For evaluation of alveolar bone resorption, we measured the linear bone loss, the bone volume (BV), and the bone mineral density (BMD). The area around the M2 on both the ligated and unligated sides of each sample was measured by following a selection of a three-dimensional region of interest (ROI) as described below. In terms of periodontal defects caused by experimental periodontitis, most bone resorption occurred around the roots of the teeth, especially below the roofs of the furcations and above the root apexes.
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We took advantage of this characteristic and defined the horizontal apical borders of the ROIs as the standard plain composed of all the M2's root apexes in each sample. The horizontal coronal border included all the crowns of the teeth. As for the vertical border, the most mesial cusp of M3 and the most distal cusp of M1 were assigned as mesial and distal endpoint landmarks because the range between the borders was the most consistent among samples. Moreover, we legislated the palatal contour of the root as the palatal border and included all buccal bones and teeth for the buccal border. Thus, we calculated each parameter for the ROIs ( Figure S1 ).
| Linear bone loss
The bone height was examined on the buccal side of the M2 at three sites corresponding to the mesial cusp, buccal groove, and distal cusp on a two-dimensional reconstruction of the ROI for each sample by a desktop micro-CT system. It was measured as the distance between the cemento-enamel junction (CEJ) and the alveolar bone crest (ABC). Following the discrimination of three sites that were subjected to bone height changes after ligation, each of them was compared separately with the contralateral unligated position. They were conditioned as follows: Each of the three-site CEJ-ABC distances at the ligated position in each mouse was estimated and subtracted from the corresponding distance of the three-site CEJ-ABC distances at the contralateral unligated position in the same mouse.
The scores of each side were averaged. Micrometer and plus values showed bone resorption compared with unligated side. 
| Quantitative real-time polymerase chain reaction for gingival tissues
Gingival tissues around the maxillary M2 were resected 8 days after ligation (n = 6 in both the IMD and CMC groups). The tissue samples were taken from both the buccal and palatal sides. The buccopalatal width was 1 mm from the gingival margin of the teeth, and the me- 
| Histological analysis of periodontal tissue
On day 8 after ligation, the skin of the maxilla was removed and immersed in 4% paraformaldehyde in a phosphate-buffered saline Figure S2 shows all the number of samples and the analyses in this study, which are described above. Each result was expressed as mean ± standard error of the mean (SEM). Before statistical analysis, it was verified that all the data were normally distributed. A one-way factorial analysis of variance (ANOVA) with the Tukey correction was applied to test the significant difference in multiple comparisons. Student's t test was performed for two group comparisons.
| Statistical analysis
Statistical analysis was conducted by using EZR (Saitama Medical
Center, Jichi Medical University, Saitama, Japan). All the tests considered P < 0.05 were statistically significant. 
| RE SULTS
| Systemic influence on the animals
| Determination for the optimum concentration of IMD-0354
To determine the optimum concentration of IMD-0354 on ligatureinduced periodontitis, we performed a ligature experiment using IMD-0354 (1, 5, and 10 mg/kg; n = 8, 7, and 9, respectively) or CMC (n = 9) on the mice. We performed a micro-CT analysis and calculated RBVF for the alveolar bone around maxillary M2 on both the ligated and unligated sides. In the group injected with IMD-0354 (10 mg/kg), there was significant suppression of bone resorption compared to the other groups, namely the groups injected with IMD-0354 (1 and 5 mg/kg) or CMC (P < 0.05, Figure 1 ).
Thus, we determined 10 mg/kg as the optimum concentration of IMD-0354.
| Linear bone loss as alveolar bone resorption
Periodontal inflammation was artificially developed by the ligature around the upper right M2s of the mice. On day 8 after applying F I G U R E 1 Determination for the optimum IMD-0354 concentration. To determine the optimum concentration of the reagent for ligature-induced periodontitis in mice, we compared four types of the reagents, which were IMD 1 (n = 8), 5 (n = 7), 10 (n = 9) mg/kg, and CMC (n = 9), as a preliminary experiment to calculate RBVF = (bone volume of ROI for unligated side−bone volume of ROI for ligated side)/bone volume of ROI for unligated side. The values are expressed as mean ± SEM. *P < 0.05 and **P < 0.01 compared to the IMD 10 mg/kg group 8 d after ligation, respectively. IMD, IMD-0354 (N-(3,5-Bis-trifluoromethyl-phenyl)-5-chloro-2-hydroxy-benzamide); CMC, carboxymethylcellulose; RBVF, resorbed bone volume fraction; ROI, region of interest the ligature, the distances between the CEJ and the ABC of the three sites, the mesial cusp, buccal groove, and distal cusp, were calculated using micro-CT imaging and analyzing software after the mice in both IMD and CMC groups (n = 9 each) were sacrificed ( Figure 2A ,B,C,D). Both the groups showed significant linear change in alveolar bone resorption around the M2s on the ligated side compared to the unligated side. In other words, the data showed that the average distances from the CEJ to the ABC in both the CL and IL groups significantly increased compared to the C and I group on day 8, respectively (data not shown). More importantly, the linear bone loss at the buccal groove and distal cusp sites in the CMC group was significantly stronger than in the IMD group (P < 0.05, Figure 2E ).
There was no significant difference, but there was a tendency of suppression at the mesial cusp site in the IMD group compared to the CMC group.
| Volumetric bone loss by micro-CT analysis
We could gain volumetric parameters, such as BV, BV/TV, and BMD for bone resorption, by extracting all teeth on the CT data of ROIs for both the IMD and CMC groups (n = 9 each). The surface quality of the bone in the CL group was rougher than that in the IL group ( Figure 3A,B) . Ligature-induced bone loss was significantly observed in both the CL and IL groups compared to the C and I groups, respectively, in terms of BV (P < 0.01, Figure 3C ). Above all, there was significant suppression of volumetric bone resorption as a BV/TV in the IMD group compared to the CMC group (P = 0.01, Figure 3E ).
We also measured BMD change for the residual alveolar bone around the second molar on the ligated side compared to the unligated side. The result of the BMD change was not significant; however, there was tendency to suppress BMD change in the IMD group compared to the CMC group throughout the observation period ( Figure 3A ,B,D).
| Relative mRNA expression levels between the ligated and unligated gingival tissues
To evaluate the effects of the IKK inhibitor on periodontal inflammation, we examined the relative mRNA expression levels of bone metabolism-related and proinflammatory genes in gingival tissues both on the ligated and unligated sides of the IMD and CMC groups (n = 6 each). We compared them 8 days after ligation to assess the pathophysiological change, which is relevant to ligature-induced periodontitis. Each result was analyzed using ΔCt value normalized by Gapdh housekeeping gene. 14 In the gingiva between the C and I groups, which are unligated gingival groups, no significant difference of the mRNA expression levels in IL-1 beta, TNF-alpha, Rankl, and
Opg were observed (data not shown).
In the ligated gingiva of both the IMD and CMC groups, which were namely IL and CL groups, all of the expression levels were indicated as fold inductions according to those in the unligated side of both the IMD and CMC groups, which were namely I and C groups, respectively. The relative mRNA expression level of Rankl in the IMD group was significantly lower than that in the CMC group 8 days after ligation (P < 0.05, Figure 4C ). On the contrary, the CMC and IMD groups, a significant difference within the IMD group between the I and IL groups was not detected. There was, however, a statistical up-regulation of the mRNA expression in the CL group compared to the C group, which was within the CMC group (P < 0.05, data not shown).
| Evaluation of tartrate-resistant acid phosphatase-positive multinucleated cells
To evaluate osteoclasts in periodontal tissues histologically, we examined the samples from both the IMD and CMC groups with F I G U R E 4 Relative mRNA expression levels of the ligated gingiva to the unligated gingiva between mice in the CMC and IMD groups. Relative mRNA expression levels at the ligated gingiva of (A) IL-1 beta, (B) TNF-alpha, (C) Rankl, and (D) Opg were compared to the unligated gingiva. These levels were expressed as the fold induction according to that in the unligated gingiva. The values are expressed as mean ± SEM (n = 6 each). *P < 0.05 compared to CMC group. IL-1 beta, interleukin-1 beta; TNF-alpha, tumor necrosis factor-alpha; Rankl, receptor activator of nuclear factor kappa-B ligand; Opg, osteoprotegerin; CMC, control group (mice); IMD, test group (mice) rounding M2 compared to the C and I groups, respectively. We assessed the bone resorption by comparing the relative number of both groups of mice, which stands for subtraction of the number in unligated side from that in ligated side. In the CMC group, the difference between the average numbers of the cells in both sections of the ligated and unligated side significantly increased compared to that in the IMD group (P < 0.05, Figure 5I ). In addition, several holes in the bone, which seem to be Howship lacunae,
were observed on the diseased site, particularly in the CMC group mice ( Figure 5A -H).
| D ISCUSS I ON
In the present study, the bone loss in the CMC group was significantly stronger than that in the IMD group. This may indicate that the ligature-induced bone resorption was suppressed by IMD-0354, a novel IKK inhibitor.
| NF kappa-B is critical for RANKL-induced osteoclast differentiation
Nuclear factor kappa-B signaling is an essential pathway for RANKL-induced osteoclast differentiation and for the function and activation of B and T cells. Both of them are critical sources of RANKL-and RANKL-related cytokines such as IL-1 and TNFalpha in inflammation. [15] [16] [17] [18] According to our results, the mRNA expression of Rankl was significantly down-regulated in the IMD group compared to the CMC group. Therefore, the IKK inhibitor is considered to have a role in down-regulating Rankl expression by suppressing NF kappa-B.
There is a report revealing that inhibition of NF kappa-B activation reduces RANKL production and amplifies the direct regulatory effect for bone resorption and osteoclastogenesis. 19 Another report demonstrated that the control of NF kappa-B led to inducing apoptosis of osteoclasts and suppression of the bone resorption by these cells. 20 Furthermore, osteoclasts are MNCs, which have the ability to form resorption lacunae and tartrate-resistant acid phosphatase (TRAP). 21 From our study, it was found that the relative number of TRAP-positive MNCs significantly decreased in the IMD group compared to the CMC group. This means that inhibition of NF kappa-B by IMD-0354 might suppress the differentiation of osteoclasts.
Some reports verified that the suppression of inflammation can impede bone resorption resulted from periodontitis. 22, 23 In our morphometric analysis, there was significant inhibition of bone loss such as linear bone loss, RBVF, and BV/TV by IMD-0354, the anti-inflammatory reagent. This reagent plays a critical role in the suppression of bone resorption.
Judging from the present results with the reports stated above, it is considered that down-regulation of NF kappa-B occurred decreasing Rankl expression and the number of TRAP-positive osteoclasts. We assumed that the condition inhibited bone resorption in the IMD-treated group.
| The influence of the IKK inhibitor
As for the systemic changes, our results showed no significant difference in body weight change among the groups. This is consistent with previous reports. 10, 11 In addition, there is a report indicating that there was no significant change in body weight as well as the blood chemistry for BUN, ALP, AST, ALT, and creatinine compared to the control group. 
| IKK inhibitor has the potential to regulate periodontitis
To date, the target of periodontal treatment has been causative agents, such as bacteria and plaque, mainly by mechanical removal. Some reports investigated the efficacy of medication therapy for periodontal disease through an in vivo study. 26, 27 However, few studies have used effective medication selectively for periodontal inflammation. 28 This suggests that medication therapy has not evolved a great deal in the periodontal field. In the medical field, many reports have studied medication therapy, including the application of IKK inhibitor. [5] [6] [7] 10, 11, 24, 25 Since NF-kB plays a key role in the inflammatory pathway, IKK inhibition has the potential ability to treat and prevent pulmonary, cardiovascular, malignant, allergic, and other diseases. IMD-0354 is the inhibitor to phosphorylate IkB and to affect through inhibition of IKK-beta. 5 Despite its utility, the reagent has hardly been applied in the dental field, especially in the periodontal area. This is the first study to examine whether IKK inhibitor is efficacious for the inhibition of periodontitis. According to the results, IMD-0354, the novel IKK inhibitor, might exert an anti-inflammatory effect, leading to suppression in bone resorption in the ligature-induced periodontitis model. In short, the selective inhibition of NF kappa-B could be implicated in the suppression of Rankl-inducing bone loss.
| The improvements and the future prospect of the study
Although the effectiveness of the IKK inhibitor on the suppression of periodontal inflammation was suggested for the first time in this study, there were some points at issue, which were sample size and the way of administration. According to the ARRIVE guideline, all the in vivo studies should be calculated the sample size in advance. 29 Because this study was the first trial to examine the impact of IKK inhibitor on periodontitis even if it was animal model, the calculation could not be performed. This is the limitation of the study, and we have to consider it in the future study.
Also, the use of the reagent can be further developed. Our study provided the mice with IKK inhibitor intraperitoneally. However, the efficiency of its introduction may be worse than that of the local introduction toward periodontal tissue directly. There is some research examining the effect of a particular medication on periodontal inflammation by microinjection into the periodontal tissue. 30, 31 Given that the IKK inhibitor can be applied clinically for periodontal therapy, the most effective way to introduce it
and a suitable animal model should be recommended. In future studies, we have to consider the treatment model for periodontitis, the dose, and efficacy of other introduction methods such as microinjection. If the novel introduction of IKK inhibitor for periodontitis is invented, the extent of its use will expand in the future.
| CON CLUS ION
In conclusion, this present study suggests that inhibition of IKK via down-regulation of NF kappa-B may provide periodontal patients with an effective approach to prevent or suppress the disease.
